Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $42.3900 (2.47%) ($42.3900 - $42.3900) on Fri. Apr. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.59% (three month average) | RSI | 31 | Latest Price | $42.3900(2.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.2% a day on average for past five trading days. | Weekly Trend | TGTX declines -5.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(63%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.795% in a week (0% probabilities). VIXM(-42%) VXX(-36%) UUP(-18%) IGOV(-4%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.795% (StdDev 3.59%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.25(-23.92%) | Inflection Point | Yes | Resistance Level | $44.68 | 5 Day Moving Average | $41.44(2.29%) | 10 Day Moving Average | $43.09(-1.62%) | 20 Day Moving Average | $44.68(-5.13%) | To recent high | -21.7% | To recent low | 5.9% | Market Cap | $5.369b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |